EA200501577A1 - DERIVATIVES 4- (2-PHENYLSULPHANYLPHENYL) PIPERIDINE AS SEROTONIN REDUCING INHIBITORS - Google Patents

DERIVATIVES 4- (2-PHENYLSULPHANYLPHENYL) PIPERIDINE AS SEROTONIN REDUCING INHIBITORS

Info

Publication number
EA200501577A1
EA200501577A1 EA200501577A EA200501577A EA200501577A1 EA 200501577 A1 EA200501577 A1 EA 200501577A1 EA 200501577 A EA200501577 A EA 200501577A EA 200501577 A EA200501577 A EA 200501577A EA 200501577 A1 EA200501577 A1 EA 200501577A1
Authority
EA
Eurasian Patent Office
Prior art keywords
phenylsulphanylphenyl
serotonin
piperidine
derivatives
reducing inhibitors
Prior art date
Application number
EA200501577A
Other languages
Russian (ru)
Other versions
EA010869B1 (en
Inventor
Аск Пюшль
Бенни Банг-Андерсен
Мортен Йергенсен
Томас Руланд
Стенсбей Тине Брайан
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36091716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200501577(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2004/000244 external-priority patent/WO2004087156A1/en
Publication of EA200501577A1 publication Critical patent/EA200501577A1/en
Publication of EA010869B1 publication Critical patent/EA010869B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к соединениям, представленным общей формулой (I), в которой заместители определены в описании заявки. Соединения полезны при лечении аффективных расстройств, таких как депрессия, тревожных расстройств, включающих генерализованное тревожное состояние, паническое расстройство и обсессивно-компульсивное расстройство.The invention relates to compounds represented by the general formula (I) in which the substituents are defined in the application description. The compounds are useful in treating affective disorders such as depression, anxiety disorders, including generalized anxiety, panic disorder, and obsessive-compulsive disorder.

EA200501577A 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl) piperidine derivatives as serotonin reuptake inhibitors EA010869B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300520 2003-04-04
PCT/DK2004/000244 WO2004087156A1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors

Publications (2)

Publication Number Publication Date
EA200501577A1 true EA200501577A1 (en) 2006-04-28
EA010869B1 EA010869B1 (en) 2008-12-30

Family

ID=36091716

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501577A EA010869B1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl) piperidine derivatives as serotonin reuptake inhibitors

Country Status (10)

Country Link
KR (1) KR101107536B1 (en)
CN (1) CN1780622A (en)
AR (1) AR043965A1 (en)
BR (1) BRPI0408647A (en)
CL (1) CL2004000725A1 (en)
EA (1) EA010869B1 (en)
IS (1) IS2676B (en)
NZ (1) NZ541859A (en)
UA (1) UA81472C2 (en)
ZA (1) ZA200507181B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200932225A (en) * 2007-12-14 2009-08-01 Lundbeck & Co As H 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
CN105348204B (en) * 2015-11-18 2018-09-14 乳源瑶族自治县大众药品贸易有限公司 1- heterocycles -2- (Heteroarylthio) benzene derivatives and its application method and purposes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
PL355289A1 (en) * 1999-10-13 2004-04-05 Pfizer Products Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
UA81749C2 (en) * 2001-10-04 2008-02-11 Х. Луннбек А/С Derivated of phenylpiperazine as serotonin reuptake inhibitorS

Also Published As

Publication number Publication date
ZA200507181B (en) 2007-03-28
IS2676B (en) 2010-09-15
BRPI0408647A (en) 2006-03-07
AR043965A1 (en) 2005-08-17
UA81472C2 (en) 2008-01-10
CL2004000725A1 (en) 2005-02-18
NZ541859A (en) 2008-10-31
IS7996A (en) 2005-08-22
KR20050119681A (en) 2005-12-21
KR101107536B1 (en) 2012-01-31
EA010869B1 (en) 2008-12-30
CN1780622A (en) 2006-05-31

Similar Documents

Publication Publication Date Title
CY1108464T1 (en) Piperidine 4- (2-phenylsulfanyl-phenyl) derivative of piperidine as serotonin re-uptake inhibitors
EA200400498A1 (en) Phenylpyrazine derivatives as inhibitors of serotonin reuptake
ATE360627T1 (en) PYRROLIDINDONE-SUBSTITUTED PIPERIDINE PHTHALAZONES AS PDE4 INHIBITORS
NO20055205L (en) 4- (2-Phenylsulfanyl-phenyl) -1,2,3,6-tithropyridine derivatives as serotonin uptake inhibitors
CY1108230T1 (en) 2- (1H-INDOLYSULFANYL) -BENZYLAMINE PRODUCTION AS SSRI
NO20055206L (en) 4- (2-phenyloxyphenyl) -piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
NO20050270L (en) New compounds, their use and manufacture
ATE471320T1 (en) 4-AMINOPIPERIDINE DERIVATIVES AS INHIBITORS OF MONOAMINE ABSORPTION
ATE532514T1 (en) PIPERIDINE AND PIPERAZINE DERIVATIVES
EA200501577A1 (en) DERIVATIVES 4- (2-PHENYLSULPHANYLPHENYL) PIPERIDINE AS SEROTONIN REDUCING INHIBITORS
EA200501580A1 (en) DERIVATIVES OF 4- (2-PHENYLOXYPHENYL) PIPERIDINE OR -1,2,3,6- TETRAHYDROPYRIDINE AS SEROTONIN RETURN CAPTURE
DE602004019698D1 (en) MORPHOLINE DERIVATIVES AS INHIBITORS OF THE RECOVERY OF NOREPINEPHRIN
DE602004009306D1 (en) 3,4-DIHYDRO-1H-CHINOLIN-2-ON DERIVATIVES AS NOREPINEPHRINE RECOVERY INHIBITORS
EA200600945A1 (en) DERIVATIVES OF MORFOLIN AS AN INHIBITORS OF THE REPEATED CAPTURE OF NORADRENALINE
CA2521030A1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
HRP20070123A2 (en) Phenyl-piperazine derivatives as serotonin reuptake inhibitors

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU